how long should l-carnitine cycle be is Underrated. New Meta Review Reminds Us Why The Role of l-Carnitine in

Clinical Studies The prolactin-lowering efficacy of DOSTINEX was demonstrated in 647 females with hyperprolactinemic disorders (including 55% microprolactinomas, 7% macroprolactinomas, 3% empty sella syndromes, and 3% idiopathic) in two randomized, double-blind, studies: one 4-week placebo-controlled dose-response study with an 12-month open-label extension (Study 1) and one 8-week active comparator study comparing DOSTINEX and bromocriptine with 16-week open extension (Study 2)

The authors found that the mean level of L-carnitine was higher in preterm infants, and the number of cases with normal L-carnitine levels in red blood cells after supplementation was significantly higher than that in the placebo group (42)

doi: 10.1016/j.jep.2016.11.036

doi: 10.1016/j.cell.2006.06.057